:: ±Û´äº¯ ::
ÀÌ ¸§
ÆÐ½º¿öµå
À̸ÞÀÏ
ȨÆäÀÌÁö
¿É ¼Ç
html
Á¦ ¸ñ
> > > î¤úÞÓÛÑûàõÜÁËíã¼íÞñ飬õ±Ðäù±××ÌÍäªüùø¸£¨Super P Force ûä Super Vidalista£© 줡¸ìéΨÔÒãÁú°Ì½ðÄàÝæ¨ÚúÑÃÙý𹡹îÜüùÍý£¬ãöáÜà÷為æðÚ¦ü¥ð¹¡£úÉÒýÑûàõû¿Ðô£¬它ϼÌåêóä§麼ãêÐôñýô¥£¿為ä§麼Ü×éÄýÒöæÅíþãÁÊà¡¢éÑÒöð«ã®ÚúÑÃÌãÓø£¿ÐÑô¸ö¦Óá你ä¢ìýÖõú°îÏγìÔÓøæðáÑ產ù¡îÜ¡¸à÷ÝÂѦ𤡹模¸å·×âΡùÊ¡¹¡£ > > 22121212.png > > ìé¡¢õ±Ðäù±××ÌÍäªüùø¸ãÀä§麼£¿ > õ±Ðäù±××ÌÍäªüùø¸£¨Super P-Force¡¢Super Vidalista£© ãÀë¦ìÔÓøå·óß AMBITREE ßæ產îÜìéγÑûàõÍíÒöäªüùÛÕÛ°å·¡£ > ØßÎ¨å·ø¸Ì¿ùêÖõÕ×ÓÞêóüùà÷Ý£º > > Ó¹ÚÕà¤ï⣨Dapoxetine£©100mg£ºñ«é©éÄåÚö½ÖûðÄàÝ£¨Premature Ejaculation, PE£©£¬ãÀÙÍîñêæìéù¬ÒýÏÐå·ÊøÏÑ£¨øÐÎÀñéÏÐ CFDA¡¢Ï±Øï EMA£©Ýëñ×éÄåÚðÄàÝîÜ×üßÉà÷Ý¡£ > > öâÓ¹ÕÃÞª£¨Tadalafil£©20mg£ºáÔöࡸßù××ÞÍà÷Ý¡¹£¬ñ«é©ËÇà¼ÚúÑÃÍíÒöî¡礙£¨ED£©£¬幫ð¾ëäÌìî¤àõí©Ìù»üáÜÖúì×µ¡¢Ó¹Óð×âßÌÌãÓø¡£ > > îÏåÆîÜ¡¸äªüùÛÕÛ°¡¹£¬ÞÅ ìÔÓøõ±Ðäù±××ÌÍäªüùø¸ à÷為ÔÒãÁËÇ༡¸ÌãÓøÜôð롹模¸ãÁÊàΦӡ¹îÜðüùêúþ產ù¡¡£ > > 죡¢à÷ÝÂíÂéÄѦð¤îïØüú°à° > Ó¹ÚÕà¤ï⣨Dapoxetine£©¦¡¦¡ð«ã®ÞÒïñÍóð¤ÕôîÜμËõ > ÐÆËàÚ¸ÏÐÏÐÊ«ßæÚªÐüâúíÀãòñéãý£¨NCBI£©Û¡øúîÜ×üßÉíÀÖùò¦õó£¬Ó¹ÚÕà¤ïâáÕåÚ ÓüùúþàÔ÷Éàõúì清áÈî¢ýåâ¥åäð¤ð¥£¨SSRI£©£¬Òöî¤ÓãÁÊàÒ®ð«ã®ñéõÒãêÌèñéîÜúì清áÈÒØÓø¡£ > úì清áÈ£¨Serotonin£©ù¬ãÊ為¡¸æÅãÁãêÌèì×í¡¹£¬Òöåäð¤Î¦ÓøýéÝÇ¡¢æÅíþÞÒïñãÁÊà¡£ > > ×üßÉ研ϼíÀÖùúéãÆ£º > > Ü×éÄÓ¹ÚÕà¤ïâ 30¢¦60mg ý£¬ÑûàõøÁгëäÔ³Ò®ÞÒïñíÖÜÑãÁÊࣨIELT£©Ê¦æÅíþ 2.5¢¦3Ûᣠ> > õ±Ðäù±××ÌÍäªüùø¸ñéð¥ÕáÍÔÓ¹ 100mg£¬æÅãÁüùÍýÌÚúéîÊ£¬ÓßåÚñéñìÓøðÄàÝðéÏØüùÍýÌÚè±ïÒ¡£ > > öâÓ¹ÕÃÞª£¨Tadalafil£©¦¡¦¡強ûùÚúÑÃÌãÓøæ¨ò¥ÎùÓø > öâÓ¹ÕÃÞªáÕåÚ PDE5 åäð¤ð¥ ×¾å·Úª£¬ñ«é©íÂéÄãÀÛ¯鬆ëäÌìúØúô÷îÜøÁüÁÑ¿£¬õµòäúìäû×µìý£¬ËÇà¼ÚúÑÃî¡礙¡£ > ÐÆËàá¦Í£êÛßæðÚòÄ£¨WHO£©æ¨Ú¸ÏÐ FDA îÜ研ϼÜÃͱò¦õó£¬Ü×éÄ 20mg öâÓ¹ÕÃÞªý£¬å·üùʦë«ò¥ íþÓ¹ 36 á³ãÁ£¬îÏå¥ãÀ它ù¬öà為¡¸ñÎØÇå·¡¹îÜê«ìס£ > > Ó×îÏÕ×ðúà÷ÝÂÌ¿ùêý£¬ÒöåÓÑûàõî¤àõßæüÀñé既Òö¡¸öá啟ÔÑ¡¢Òöò¥Îù¡¹£¬ÓÞøëð«ã®ïÚô÷àõßæüÀù¡òõ¡£ > > 523232.png > > ß²¡¢為ä§麼àÔ÷Éõ±Ðäù±××ÌÍäªüùø¸£¿ > äªüùùêì飺ÔÒãÁËÇà¼ðÄàÝ£¨PE£©æ¨ÚúÑÃÍíÒöî¡礙£¨ED£©¡£ > > öááÜÑÃüù£ºÜ×éÄýå³ 1¢¦2 á³ãÁýå⥣¬即ʦòäìýüùÍýÑ¢¡£ > > å·üùè±ïÒ£ºÓ¹ÚÕà¤ïâæÅãÁ£«öâÓ¹ÕÃÞªð¾Úú£¬äªñìíÂéÄÜôöèÊ¡£ > > ÍÔàõʤÝßÓÎòåÚê«óßå·£¨Priligy£«Cialis£©ðÚù꣬ìÔÓøõ±Ðäù±××ÌÍʤ̫ÌÚöÑÚÅ¡£ > > 232323.png > > ÞÌ¡¢ÞÅéÄËïì¡æ¨ñ¼ëòÞÀú£ > Ëïì¡åÚàõßæüÀîñ 1¢¦2 á³ãÁÜ×éÄìéΨ£¬ì¤ßÈè®ËÒâ©áêÜס£ > > ìéô¸ÐÁùÚÜ×éÄìéó£¬ùØóæ¨Ðìöâùß PDE5 à÷ÝÂå·Úª£¨åýêÎì»Ë¼¡¢äÅêÎíࣩÔÒãÁÞÅéÄ¡£ > > ÐÁî¤àõí©Ìù»î¦üå產ßæÚúÑÃüùÍý¡£ > > å´êóãýúìηòðÜ»¡¢ÊÜãìÍíÒöì¶ßÈûäïáî¤Ü×éÄõ¦ß«ç¤å·Úªíº£¬ôëà»í¿âóîöåöì¢ÞÔ¡£ > > çé¡¢ÏíêÎì¢ùÊóÑÍÅíÀÖù > McMahon CG, et al. Dapoxetine: A Novel Treatment for Premature Ejaculation. Lancet. 2009. > > Porst H, et al. Efficacy and Safety of Tadalafil Once Daily in Men with Erectile Dysfunction. European Urology. 2014. > > World Health Organization (WHO) – Global Guidelines for Sexual Health and Erectile Dysfunction Management. > > National Center for Biotechnology Information (NCBI) – Clinical Trials on Dapoxetine and Tadalafil Combination Therapy. > > 12122.png > > Ì¿åÞ > õÅÌ¿ÕÎà㣬õ±Ðäù±××ÌÍäªüùø¸£¨Super P-Force / Super Vidalista£© ÜôÐÁãÀðÄàÝö½ÖûîÜúÔãæÛ°äУ¬ÌÚãÀÌ¿ùêæÅãÁæ¨ð¾ÚúäªñìΡÐüîÜÓÛøú¡£ > ÙíÖåãÀßÌËÇ༡¸ãÁÊàΦӡ¹îÜÍÝèö£¬ûäãÀ¡¸ÌãÓøÜôð롹îÜ尷尬£¬它Ô´Òöð«ÍêìéËÁîïÛ°êÈîÜú°Ì½Û°ú¾¡£ > î¤îöåöì¢ÞÔËïì¡ù»ïáü¬ÞÅéÄ£¬åÓí»ãáæ¨Ø»ðëî¢óüÞÏýàõßæüÀ¡£ > > ßÓμ產ù¡õÏôÀ:äû÷¾â©ÍýÚ«ÍýÔÐäÅêÎíà äû÷¾êÎì»Ë¼ ïáù¡úÅùûÖÕñéì¢ ÓìÏÐýÙ螞ëü Ú¸ÏÐýÙÑÑ ìéßÌö¦Ìã ü¤佗ãêÓ¡ ìé炮Óðô¸ÕÕð¯ø¢ÓÛã®Ðä÷ú ÌÚÒý產ù¡ßÙï×òäìýˬäÅå·ÏÑwww.kl19.twí¿âó24á³ãÁËÔÜ×line:kl198888 > > æÅãß阅读£ºPOXET-60 îêùêñéÒ´Ñûàõ嗎£¿45 á¨ì¤ß¾ðéÏØÜ×éÄËïì¡ >
¸µÅ© #1
¸µÅ© #2
ÆÄÀÏ÷ºÎ
¿ÞÂÊÀÇ ±ÛÀÚ¸¦ ÀÔ·ÂÇϼ¼¿ä.